VEGF Receptor Phosphorylation Status and Apoptosis is Modulated by a Green Tea Component, Epigallocatechin-3-gallate (EGCG) in B cell Chronic Lymphocytic Leukemia

作者: Yean K. Lee , Nancy D. Bone , Ann K. Strege , Tait D. Shanafelt , Diane F. Jelinek

DOI: 10.1182/BLOOD-2003-08-2763

关键词:

摘要: We recently reported that chronic lymphocytic leukemia (CLL) cells synthesize and release vascular endothelial growth factor (VEGF) under normoxic hypoxic conditions. CLL B also express VEGF membrane receptors (VEGF-R1 VEGF-R2), suggesting they use as a survival factor. To assess the mechanism of apoptosis resistance related to VEGF, we determined impact on cells, studied epigallocatechin-3-gallate (EGCG), known receptor tyrosine kinase (RTK) inhibitor, status viability cells. VEGF165 significantly increased apoptotic immunoblotting revealed VEGF-R1 VEGF-R2 are spontaneously phosphorylated EGCG apoptosis/cell death in 8 10 samples measured by annexin V/propidium iodide (PI) staining. The increase V/PI staining was accompanied caspase-3 activation poly-adenosine diphosphate ribose polymerase (PARP) cleavage at low concentrations (3 microg/mL). Moreover, suppressed proteins B-cell leukemia/lymphoma-2 protein (Bcl-2), X-linked inhibitor (XIAP), myeloid cell leukemia-1 (Mcl-1) Finally, (3-25 microg/mL) phosphorylation, albeit incompletely. Thus, these results suggest signaling regulates signals interruption this autocrine pathway caspase subsequent leukemic death.

参考文章(47)
Gera Neufeld, Ofra Kessler, Yael Herzog, The Interaction of Neuropilin-1 and Neuropilin-2 with Tyrosine-Kinase Receptors for VEGF Neuropilin. ,vol. 515, pp. 81- 90 ,(2002) , 10.1007/978-1-4615-0119-0_7
Irene M. Pedersen, Shinichi Kitada, Lorenzo M. Leoni, Juan M. Zapata, James G. Karras, Nobuhiro Tsukada, Thomas J. Kipps, Yong Sung Choi, Frank Bennett, John C. Reed, Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood. ,vol. 100, pp. 1795- 1801 ,(2002) , 10.1182/BLOOD.V100.5.1795.H81702001795_1795_1801
Alvaro Aguayo, Elihu Estey, Hagop Kantarjian, Taghi Mansouri, Cristi Gidel, Michael Keating, Francis Giles, Zeev Estrov, Bart Barlogie, Maher Albitar, Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood. ,vol. 94, pp. 3717- 3721 ,(1999) , 10.1182/BLOOD.V94.11.3717
Walter Fiedler, Ullrich Graeven, Süleyman Ergün, Sandra Verago, Nerbil Kilic, Marcus Stockschläder, Dieter K. Hossfeld, Vascular Endothelial Growth Factor, a Possible Paracrine Growth Factor in Human Acute Myeloid Leukemia Blood. ,vol. 89, pp. 1870- 1875 ,(1997) , 10.1182/BLOOD.V89.6.1870
Shinichi Kitada, Janet Andersen, Sophie Akar, Juan M. Zapata, Shinichi Takayama, Stanislaw Krajewski, Hong-Gang Wang, Xin Zhang, Florencia Bullrich, Carlo M. Croce, Kanti Rai, John Hines, John C. Reed, Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses Blood. ,vol. 91, pp. 3379- 3389 ,(1998) , 10.1182/BLOOD.V91.9.3379
Jerry W. Hussong, George M. Rodgers, Paul J. Shami, Evidence of increased angiogenesis in patients with acute myeloid leukemia Blood. ,vol. 95, pp. 309- 313 ,(2000) , 10.1182/BLOOD.V95.1.309
Peter Carmeliet, Mechanisms of angiogenesis and arteriogenesis. Nature Medicine. ,vol. 6, pp. 389- 395 ,(2000) , 10.1038/74651
Michael Klagsbrun, Seiji Takashima, Roni Mamluk, The Role of Neuropilin in Vascular and Tumor Biology Neuropilin. ,vol. 515, pp. 33- 48 ,(2002) , 10.1007/978-1-4615-0119-0_3
R M Shaheen, L M Ellis, C Liang, S Weitman, A L Hannah, J M Cherrington, L K Shawver, B D Smolich, D B Mendel, A D Laird, R A Blake, Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. Anti-cancer Drug Design. ,vol. 15, pp. 29- 41 ,(2000)